NCT05446948View on ClinicalTrials.gov

Observation of the Efficacy of Different Vitrectomy Systems to Treat Proliferative Diabetic Retinopathy

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

July 11, 2022

Primary Completion Date

June 1, 2023

Study Completion Date

June 1, 2023

Conditions
Proliferative Diabetic RetinopathyVitrectomy
Interventions
DEVICE

beveled 27G+ vitrectomy system

The device is a novel 27G+ vitrectomy system, whose probe tip is beveled.

DEVICE

standard 25G+ vitrectomy system

The device is a traditional instrument, and its probe tip is flat.

Trial Locations (1)

300386

Tianjin Medical University Eye Hospital, Tianjin

All Listed Sponsors
lead

Tianjin Medical University Eye Hospital

OTHER